Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1270799

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1270799

Global Biosimilars Market Size, Share, Growth Analysis, By Indication Type(Auto-Immune Diseases, Blood Disorder), By Product(Human Growth Hormone, Erythropoietin) - Industry Forecast 2022-2028

PUBLISHED:
PAGES: 165 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Biosimilars Market size was valued at USD 15.6 billion in 2021 and is poised to grow from USD 19.27 billion in 2022 to USD 128.76 billion by 2030, growing at a CAGR of 23.5% in the forecast period (2023-2030).

A biosimilar, often known as a biologic, is a biopharmaceutical product that is very similar to a typical biologic drug. Cells or living organisms construct its intricate molecular system. When the patents on a biologic medication expire, businesses concentrate on getting approval from the relevant regulatory authority to begin producing biosimilars. To be branded as a biosimilar, a biological drug must be shown to be equivalent in terms of quality, safety, and effectiveness. Because of their more complex development and higher development costs, biosimilars are substantially more expensive than generic medications.

This business is now being driven by a number of factors, including the patent expirations of prominent biological medicines, decreasing pricing, an increase in the prevalence of chronic illnesses, and cost-cutting initiatives by governmental organisations and third-party providers.

Top-down and bottom-up approaches were used to estimate and validate the size of global Biosimilars Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Segments covered in this report

The Global Biosimilars Market segmentation is based on indication type, product type, and region. Based on indication the market is segmented into auto-immune diseases, blood disorders, diabetes, oncology, growth deficiency, and female infertility. Based on product the market is segmented into human growth hormone, erythropoietin, monoclonal antibodies, insulin, interferon, colony-stimulating factors, and others. Based on region the Global Biosimilars market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Due to their low cost, biosimilars are in more demand, which will help the market.

The development expenses of biosimilars are less than those of the original biologics. Less expensive R&D costs result in lower biosimilar prices. Less priced biosimilars frequently result in lower prices for reference biologics because of supplier pricing competition. Due to their significant cost-to-benefit ratio, biosimilar pharmaceuticals are expected to see an increase in demand in the coming years.

Growing prevalence of chronic diseases will fuel market expansion.

The prevalence of chronic illnesses is rising, which is driving up global demand. Drugs that are biosimilar are becoming more and more well-liked worldwide because to their affordability. The need for biosimilars is anticipated to expand during the projection period due to an increase in cancer cases, chronic sickness cases, and the ageing population. This is especially true for pricey proprietary medications.

Restraint

Biosimilars' development is complicated.

Producing biosimilars is a challenging and expensive procedure that requires significant financial investments, technological know-how, experience with clinical trials, research criteria, and quality control systems. Makers of biosimilars are required to make comparable investments in clinical trials and post-approval safety monitoring systems, in contrast to manufacturers of generic medications.

Market Trends

Reduced biosimilar costs will have a big impact on worldwide biosimilar demand as long as patients remain the main benefactors. The innovation's cost reductions are the newest craze among manufacturers located in growing biosimilar marketplaces. Over the course of the projection period, this will continue to be a typical trend, which will ultimately support the growth of the global biosimilars market. Additionally, biosimilar manufacturers will presumably try out new production volumes or sizes. The capacity to produce numerous biosimilar medications at a single location may be advantageous to biosimilar manufacturers during the anticipated period.

Product Code: SQSG35H2009

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Global Biosimilars Market Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
  • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
  • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
  • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
  • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
  • Exhibit: Parent Market Ecosystem Market Analysis
  • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
  • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
  • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
  • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
  • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
  • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
  • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
  • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
  • Exhibit: Data Table on Global Global Biosimilars Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
  • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
  • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
  • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
  • Competitive rivalry
  • Exhibit: Competitive rivalry Impact of key factors, 2021
  • Threat of substitute products
  • Exhibit: Threat of Substitute Products Impact of key factors, 2021
  • Bargaining power of buyers
  • Exhibit: buyers bargaining power Impact of key factors, 2021
  • Threat of new entrants
  • Exhibit: Threat of new entrants Impact of key factors, 2021
  • Bargaining power of suppliers
  • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
  • Political Impact
  • Economic impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Global Biosimilars Market by Indication Type
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Auto-Immune Diseases
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Blood Disorder
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Diabetes
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Oncology
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Growth Deficiency
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Female Infertility
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Global Global Biosimilars Market by Product
  • Market segments
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Data table on Market share 2021-2027 (%)
  • Human Growth Hormone
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Erythropoietin
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Monoclonal Antibodies
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Insulin
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Interferon
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Colony Stimulating Factors
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Others
  • Market Estimates & Forecast, 2020-2027
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • USA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Canada
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Germany
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Spain
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • France
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • UK
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Europe
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • China
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • India
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Japan
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Korea
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of Asia Pacific
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • Brazil
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of South America
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
  • Chart on Market share by country 2021-2027 (%)
  • Data Table on Market share by country 2021-2027(%)
  • GCC Countries
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • South Africa
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Rest of MEA
  • Exhibit: Chart on Market share 2021-2027 (%)
  • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
  • Total number of companies covered
  • Exhibit: companies covered in the report, 2021
  • Top companies market positioning
  • Exhibit: company positioning matrix, 2021
  • Top companies market Share
  • Exhibit: Pie chart analysis on company market share, 2021(%)
  • Pfizer Inc. (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Amgen Inc. (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Samsung Bioepis (South Korea)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Novartis AG (Switzerland)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Celltrion Inc. (South Korea)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Viatris Inc.(US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Coherus BioSciences (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Biogen (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Mylan (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Teva Pharmaceutical (Israel)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Eli Lilly (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Merck & Co (US)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
  • Biocon(Bangalore)
  • Exhibit Company Overview
  • Exhibit Business Segment Overview
  • Exhibit Financial Updates
  • Exhibit Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!